Mituri despre HPV și vaccinare. Ce trebuie să știe tinerii și părinții lor, cu Dr. Victoria Aramă

The HPV virus affects almost all sexually active people and is responsible, globally, for approximately 5% of all cancers. It is the most widespread sexually transmitted infection. These statistics show us how important prevention and testing are. However, in Romania, cervical cancer ranks third in cancer mortality. At the European Union level, Romania has the most deaths caused by this disease. Lack of information, stigmatization of patients and myths about HPV contribute to this situation. In this episode, Dr. Victoria Aramă helps us understand HPV infection and, above all, what we can do to prevent and combat it. From the moment of infection with the HPV virus to the appearance of lesions or invasive cancer, up to 20 years can pass. The evolution is slow, and this information is vital for women. Basically, if tested regularly during this interval, the chances of early diagnosis and survival increase considerably. There are over 200 strains of HPV, but the most dangerous are strains 16 and 18, responsible for approximately 70% of cervical cancer cases. We have the HPV vaccine against them. This has been and remains the target of some myths and conspiracies. How is the vaccine manufactured? Through genetic engineering. It contains only the viral protein, without viral DNA, so it cannot be contagious. Vaccination is also recommended for men. Statistical data shows that the number of infected men is even higher than that of women: one in five is HPV positive. In addition, the virus can also cause male cancers, which is why their immunization is just as important. This initiative is supported by @synevoromania Key moments: [00:02:14]: What is HPV? Classification and features [00:04:04]: Benign lesions versus oncogenic risk [00:05:01]: Weak natural immune response and reinfection [00:05:36]: Transmission routes: sexual, including oral [00:06:42]: Contaminated objects and perinatal transmission [00:07:54]: Demystifying surfaces; possible self-inoculation [00:09:57]: HPV frequency by sex and age [00:11:01]: Clearance in young women and definition of persistence [00:12:29]: Strains 16 and 18, the most oncogenic [00:13:38]: Other oncogenic strains and risks [00:14:17]: HPV involvement in other cancers [00:14:51]: Clinical features of the vulva and vagina [00:15:59]: Natural evolution towards lesions and cancer [00:17:38]: The importance of early cytological screening [00:18:00]: 16 vs 18: squamous vs adenocarcinoma [00:19:29]: From CIN1 to invasive cancer [00:20:49]: Management of CIN2: excision vs monitoring [00:21:33]: Vaccination after precancerous or cancerous lesions [00:22:09]: Natural vs. postvaccinal immunity [00:23:02]: Vaccination even if HPV-positive [00:23:23]: Studies on post-conization vaccination [00:24:03]: Conization as an indication for vaccination [00:24:17]: Vaccine composition and L1 mechanism [00:25:54]: Why do we vaccinate boys too [00:26:54]: Male and oropharyngeal cancers [00:27:15]: Adverse reactions and the fainting myth [00:29:28]: Call for vaccination and screening Want to learn more about Dr. Prof. Gheorghe Peltecu? 🩺 Instagram: Instagram: dr.gheorghepeltecu 🩺 Facebook: Facebook: Prof-Dr-Gheorghe-Peltecu-100090703298754 🩺 TikTok: TikTok: dr.gheorghepeltecu 🩺 LinkedIn: LinkedIn: prof-dr-gheorghe-peltecu Website: https://peltecu.ro #podcast #stimanustigma #synevo #medicalanalysis #gynecology #cancer #oncology #drgheorghepeltecu #medicalpodcast #uterinecancer #HPV #vaccination #virus #prevention #testing